Back to SGMT

Commodore Capital LP → SGMT

Commodore Capital LP SGMT Position History

Sagimet Biosciences Inc. • Healthcare

Quarters held
1
Latest value
$27.2M
Q3 2026
Peak value
$27.2M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$27.2M2.76M——

Other funds holding SGMT

Other Commodore Capital LP positions

RLAY

RELAY THERAPEUTICS INC

$224.5M
RLAY

RELAY THERAPEUTICS INC

$216.6M
RLAY

RELAY THERAPEUTICS INC

$169.2M
ELVN

ENLIVEN THERAPEUTICS INC

$166.2M
ALKS

ALKERMES PLC

$157.2M
ELVN

ENLIVEN THERAPEUTICS INC

$150.1M
ALKS

ALKERMES PLC

$148.5M
RLAY

RELAY THERAPEUTICS INC

$143.8M